Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Validation of WISQ in Women with Chronic Angina Treated with Ranolazine
NCT00644332Phase 4Completed
- Sponsor
- Gilead Sciences
- Start
- Nov 2007
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ranolazine in Angina Pectoris (AP), sponsored by Gilead Sciences. Started Nov 2007; status: completed.
02
Drugs
ranolazine
03
Conditions
Angina Pectoris (AP)
Beyond the preview
Go deeper on NCT00644332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00644332.